(Q41118669)

27 September 2017

Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1586980

11 October 2022

0 references

M. J. Kuffel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1586980

11 October 2022

J. M. Reid

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1586980

11 October 2022

M. M. Ames

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1586980

11 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1586980

11 October 2022

publication date

1 January 1992

1 reference

Cancer Chemotherapy and Pharmacology

27 September 2017

1 reference

27 September 2017

30

1 reference

27 September 2017

1

1 reference

27 September 2017

51-57

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00686485

27 September 2017

0 references

cites work

Cellular uptake and metabolism of daunorubicin as determined by high-performance liquid chromatography. Application to L1210 cells

1 reference

12 December 2020

Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo)

1 reference

12 December 2020

Relationship between effects on nucleic acid synthesis in cell cultures and cytotoxicity of 4-demethoxy derivatives of daunorubicin and adriamycin

1 reference

12 December 2020

Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells.

1 reference

12 December 2020

Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture.

1 reference

12 December 2020

Comparative uptake, metabolism and retention of anthracyclines by tumors growing in vitro and in vivo

1 reference

12 December 2020

Stereoselectivity of idarubicin reduction in various animal species and humans

1 reference

12 December 2020

Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitro

1 reference

12 December 2020

Comparative cellular uptake and cytotoxicity of a complex of daunomycin-low density lipoprotein in human squamous lung tumour cell monolayers

1 reference

12 December 2020

Plasma and human leukemic cell pharmacokinetics of oral and intravenous 4-demethoxydaunomycin

1 reference

12 December 2020

Antileukemic activity of 4-demethoxydaunorubicin in mice

1 reference

12 December 2020

Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells

1 reference

12 December 2020

Comparative metabolism of daunorubicin and 4-demethoxydaunorubicin in mice and rabbits

1 reference

12 December 2020

Comparative mammalian metabolism of adriamycin and daunorubicin

1 reference

12 December 2020

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

12 December 2020

Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol

1 reference

12 December 2020

Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers

1 reference

12 December 2020

Cellular pharmacodynamics of several anthracycline antibiotics

1 reference

12 December 2020

A comparison of in vitro sensitivity of acute myeloid leukemia precursors to mitoxantrone, 4'deoxydoxorubicin, 4-demethoxydaunorubicin and daunorubicin

1 reference

12 December 2020

Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells

1 reference

12 December 2020

Formation, resealing and persistence of DNA breaks produced by 4-demethoxydaunorubicin in P388 leukemia cells

1 reference

12 December 2020

Adriamycin uptake and metabolism in organotypic culture of A549 human adenocarcinoma cells according to the exposure time

1 reference

12 December 2020

Pharmacokinetics of 4-demethoxydaunorubicin in cancer patients

1 reference

12 December 2020

Comparison of Biochemical and Biological Methods in the Evaluation of New Anthracycline Drugs

1 reference

12 December 2020

DNA topoisomerases as targets for cancer therapy

1 reference

12 December 2020

Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients: a Childrens Cancer Study Group report.

1 reference

12 December 2020

DNA double-strand breaks in mammalian cells after exposure to intercalating agents

1 reference

12 December 2020

DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00686485

1 reference

Dimensions Publication ID

27 September 2017

0 references

1 reference